SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-049257
Filing Date
2022-04-25
Accepted
2022-04-25 07:30:35
Documents
12
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223640-1_def14a.htm DEF 14A 714137
2 GRAPHIC lg_zynerbapharmar-4c.jpg GRAPHIC 71402
3 GRAPHIC sg_armandoanido-bw.jpg GRAPHIC 6657
4 GRAPHIC tm223640d1-icon_chairfembw.jpg GRAPHIC 877
5 GRAPHIC tm223640d1-icon_chairperbw.jpg GRAPHIC 840
6 GRAPHIC tm223640d1-icon_compbw.jpg GRAPHIC 4249
7 GRAPHIC tm223640d1-icon_mailbw.jpg GRAPHIC 5268
8 GRAPHIC tm223640d1-icon_memberbw.jpg GRAPHIC 778
9 GRAPHIC tm223640d1-icon_memfembw.jpg GRAPHIC 871
10 GRAPHIC tm223640d1-icon_telephobw.jpg GRAPHIC 5695
11 GRAPHIC tm223640d1-px_page01bw.jpg GRAPHIC 947777
12 GRAPHIC tm223640d1-px_page02bw.jpg GRAPHIC 557885
  Complete submission text file 0001104659-22-049257.txt   2919717
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 22847326
SIC: 2834 Pharmaceutical Preparations